Author

Evan Xie

University of California, San Francisco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Assay:proteomics· 1

Frequent Co-Authors

Aaron D. GitleriD· 1 shared Alison M. Goate· 1 shared Andrea Keys· 1 shared Andrew Li· 1 shared Bernardo Aguzzoli HeberleiD· 1 shared Bertal Huseyin AktasiD· 1 shared Brian Yee· 1 shared Chang LiuiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Aaron D. GitlerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tau is an m6A-associated RNA binding protein that causes RNA dysregulation in disease

Gary Dixon, Andrea Keys, Katherine L. Rothamel, Justin McKetney, Yi Xiao Jiang, Lacey A. Gordon, Madeline L. Page, Chang Liu, Katrina Hou, Keegan Flanagan, Brian Yee, Evan Xie, Gregory A. Mohl, Emily Marzette, Julianne Jin, , Martin Kampmann

The paper identifies tau as an m6A-associated RNA binding protein that causes RNA dysregulation in MAPT coding-variant patients and V337M iNeurons.

bioRxiv · Oct 29, 2026 · PreprintMolecular Biology

An AI-Driven Framework for Discovery of BACE1 Inhibitors for Alzheimer's Disease

Evan Xie, Karin Hasegawa, Georgios Kementzidis, Evangelos Papadopoulos, Bertal Huseyin Aktas, Yuefan Deng

This paper develops an AI framework to generate and optimize BACE1 inhibitors for Alzheimer's disease, identifying 14 candidates with improved binding properties.

bioRxiv · May 15, 2024 · PreprintBiochemistry